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EDITORIAL
Site-specific multi disciplinary tumour board is an important milestone in cancer
patient’s treatment journey
Ahmed Nadeem Abbasi, Sehrish Abrar, Bilal Mazhar Qureshi
Site-specific multi-disciplinary tumour boards are being
conducted in order to achieve a consensus
recommendation before commencing the first treatment
modality of management. They are proven to be an
essential milestone in high quality cancer management
pathway. Review of contemporary literature showed a
positive relationship in the form of better treatment
outcomes in terms of survival and local control of
malignancies for patients who were discussed and
deliberated in site-specific multidisciplinary tumour
boards.1,2
In developing countries, we consider these tumour
boards as lifeline for our cancer patients.3 These tumour
boards provide us with an opportunity to review the
quality of preliminary workup, investigations and in
certain cases we do necessary changes in the tumour
staging and sub-staging. In this way, we ensure an
accurate recommendation for every case discussed in the
board. In developing countries, due to a variety of
reasons, we have observed that it is not possible to
discuss every case in a site-specific Tumour Board at every
institute. A practical solution to this problem in Pakistan
lead to the formation of City Tumuor Board which is being
attended by experts from all concerned specialities. This is
an independent, non-institutional and non-territorial
board which is being conducted on Sunday mornings at a
neutral venue. This city Tumour Board serves to all those
cancer cases who have no access to an institutional
tumour board and a thorough multi-disciplinary
discussion is sought. In 2013, a clinical audit of this noninstitutional tumour board was published in the Journal
of the Pakistan Medical Association.4
In the absence of a national cancer registry and a national
cancer plan, we can only focus on patient-centred
approaches, like the ones which improve our clinical
decision making geared towards an improvement in our
clinical outcomes. Establishment of high quality sitespecific multi-disciplinary tumour boards is one of the
examples of such patient centred, focused and practical
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endeavour. Cancer care providers serving in the
developing countries rarely have direct involvement in
the national healthcare policy-making corridors of the
country. Therefore, we take the route of addressing the
problems faced by our patients with a head on problem
solving approach. Establishment of a city Tumour Board
in 2010 is an example of this thematic plan which is only
addressing a portion of the wider problem.5
Cancer clinical practice guidelines which are published
regularly in developed countries are also over
emphasizing on the fact that we shall form properly
represented and mandated expert committees in the
form of site-specific multi-disciplinary forums which
oversee and monitor the site-specific Tumour Board in
institutions where cancer patients are managed.6
Clinical quality indicators will monitor the performance of
these Tumour Boards via looking into the quality of
recommendations made after thorough deliberations in
these meetings. With time, our learning curve is
improving and we are addressing quality of these
professional activities.7
The more we get to involve ourselves in a multidisciplinary culture, the better will be our patient centred
approach. A site-specific surgical team who is conducting
complex oncological operative procedures cannot
function without expert radiation and medical oncology
teams as most malignancies are being managed by more
than one modality of treatment. There are certain
malignancies, like locally advanced breast and rectal
cancers, in which neo-adjuvant oncological treatment is
recommended before the surgical removal of the
tumour.8 Extensive surgical procedures like whole limb
amputation, total laryngectomies and abdominoperineal
resections can be avoided, if all cancer cases are discussed
in multi-disciplinary site-specific Tumour Boards. Tumour
staging work up and biopsy of lesions is conducted by
surgical teams, as patients seek the first consultation in
surgical consulting clinics. Therefore, in most diagnosed
cases, it becomes the responsibility of the surgical team to
bring all such cases in respective site-specific boards for a
thorough discussion before embarking on the surgical
procedure. Bringing cases to the Tumour Board after the
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completion of surgery destroys the whole purpose of
these endeavours. The frequency of these boards also
plays a major role in the reluctance of bringing cases. We
recommend weekly boards to ensure swift decision
making and faster start of the first modality of the
management plan. Leaving cases in pending does not
serve the purpose and destroys the theme to establish
these multi-disciplinary teams.
Postgraduate training programmes in academic institutes
can take an extra benefit from the establishment of these
site-specific Tumour Boards. The cases can be prepared
and presented by the postgraduate trainee students and
during the process of preparation and presentation, their
clinical acumen will improve.9 Also, working in a multidisciplinary culture, we are expecting to develop future
specialists who will know their limitations and will be
eager to establish these boards in the hospitals where
they will get specialist appointments. The same dictum
applies to faculty professional growth and development.
The institutes can incorporate the participation of
concerned faculty in this activity in annual appraisal as an
integral entry under clinical services heading. We would
recommend the establishment of site-specific multidisciplinary Tumour Boards in all institutions where
cancer patients are managed.10
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